Melanin Nanoparticle-Modified Probiotics for Targeted Synergistic Therapy of Ulcerative Colitis-Reference-Cited by-同舟云学术

Melanin Nanoparticle-Modified Probiotics for Targeted Synergistic Therapy of Ulcerative Colitis

Published:2024-06-11 Issue:25 Volume:16 Page:31950-31965
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Liu Yuqin¹,Gao Caifang²,Li Gang³,Niu Zhuangzhuang³,Liu Xiaoli³,Shen Hao³,Sun Jinghua⁴^ORCID,Zhang Ruiping⁵^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Shanxi Medical University, Taiyuan 030001, China

2. Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan 030032, China

3. Shanxi Medical University, Taiyuan 030001, China

4. First Hospital of Shanxi Medical University, Taiyuan 030001, China

5. The Radiology Department of Shanxi Provincial People’s Hospital, Five Hospital of Shanxi Medical University, Taiyuan 030001, China

Funder

National Key Research and Development Program of China

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Shanxi Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.4c02914

Reference71 articles.

1. Ulcerative colitis

2. Stimulation-responsive mucoadhesive probiotics for inflammatory bowel disease treatment by scavenging reactive oxygen species and regulating gut microbiota

3. Environmental triggers in IBD: a review of progress and evidence

4. Control and dysregulation of redox signalling in the gastrointestinal tract

5. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis